Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check4 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the benralizumab Phase III study, including its study details, results, eligibility criteria, and related documents, instead of a 403 error page.SummaryDifference80%

- Check11 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA notice about NIH’s terminology transition appears above the site navigation, and the footer revision changes from v3.7.1 to v3.7.2. The study area continues to display a 403 error.SummaryDifference1%

- Check39 days agoChange DetectedThe footer’s ClinicalTrials.gov release identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error with minimal navigation, replacing the previously visible study-record content. The detailed study information appears removed or inaccessible, indicating a site access issue rather than a content update.SummaryDifference19%

- Check60 days agoChange DetectedRevision: v3.7.0 has been added and Revision: v3.6.6 has been removed. This reflects an update to the version of the study documentation referenced on the page.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.